Roche’s stock fell following its full year 2015 earnings announcement, but the fundamentals remain strong. Here’s what worked for Roche last year, and why the outlook remains bright.
Roche’s stock fell following its full year 2015 earnings announcement, but the fundamentals remain strong. Here’s what worked for Roche last year, and why the outlook remains bright.
Please to comment